The bill amends South Dakota's controlled substances schedule by adding a detailed list of opium derivatives, opiates, and hallucinogenic substances to Schedule I. This includes specific compounds such as acetylcodone, desomorphine, and various fentanyl analogs, as well as hallucinogens like DMT, LSD, and psilocybin. The legislation also clarifies the structural modifications that would classify certain substances as controlled, ensuring that any derivatives or analogs are subject to the same restrictions.

Furthermore, the bill outlines exemptions for certain substances, particularly tetrahydrocannabinol (THC), when derived from industrial hemp or FDA-approved drugs. It emphasizes the urgency of these changes by declaring an emergency, indicating that the modifications are crucial for the immediate preservation of public health and safety. The bill aims to enhance regulation of these substances to address growing concerns about misuse and to protect public safety effectively.

Statutes affected:
Introduced, 01/03/2025: 34-20B-13, 34-20B-14
Enrolled, 02/07/2025: 34-20B-13, 34-20B-14